Log in
Enquire now
‌

US Patent 11400107 Cancer treatments

Patent 11400107 was granted and assigned to NuCana on August, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
NuCana
NuCana
Date Filed
May 31, 2017
Date of Patent
August 2, 2022
Patent Applicant
NuCana
NuCana
Patent Application Number
16305162
Patent Citations
‌
US Patent 10117888 Formulation comprising a gemcitabine-prodrug
‌
US Patent 10022390 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
Patent Citations Received
‌
US Patent 11786544 Formulations of phosphoramidate derivatives of nucleoside drugs
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11400107
Patent Primary Examiner
‌
Pancham Bakshi
CPC Code
‌
A61K 31/7076
‌
A61K 31/7072
‌
A61P 35/00

Find more entities like US Patent 11400107 Cancer treatments

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.